| Host |
Mouse |
| Clone |
CH-19 |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Pepsin |
| Positive control |
Tonsil |
| Dilution |
1:25 - 1:50 |
| Isotype |
Mouse IgG1 |
| Localization |
Cell Membrane |
Cadherin (Pan)
|
Diagnostic Biosystems |
CH-19 |
0.5 ml |
Concentrate |
CE/IVD |
MOB228-05 |
-
|
| Host |
Mouse |
| Clone |
1H3 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
Diva modified Citrate pH 6.2 |
| Positive control |
Colon Carcinoma |
| Dilution |
1:100 - 1:200 |
| Isotype |
Mouse IgG1/κ |
| Localization |
Cytoplasm and Cell Membrane |
Cadherin 17
|
Biocare Medical |
1H3 |
0.1 ml |
Concentrate |
CE/IVD |
ACI3111A |
-
|
| Host |
Mouse |
| Clone |
1H3 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
Diva modified Citrate pH 6.2 |
| Positive control |
Colon Carcinoma |
| Dilution |
1:100 - 1:200 |
| Isotype |
Mouse IgG1/κ |
| Localization |
Cytoplasm and Cell Membrane |
Cadherin 17
|
Biocare Medical |
1H3 |
1 ml |
Concentrate |
CE/IVD |
ACI3111C |
-
|
| Host |
Mouse |
| Clone |
1H3 |
| Format |
Ready-to-use |
| Method |
P |
| Pretreatment |
Diva modified Citrate pH 6.2 |
| Positive control |
Colon Carcinoma |
| Dilution |
- |
| Isotype |
Mouse IgG1/κ |
| Localization |
Cytoplasm and Cell Membrane |
Cadherin 17
|
Biocare Medical |
1H3 |
6 ml |
Ready-to-use |
CE/IVD |
API3111AA |
-
|
| Host |
Mouse |
| Clone |
CB-955 |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Citrate, Enzyme |
| Positive control |
Kidney |
| Dilution |
1:150 - 1:300 |
| Isotype |
Mouse IgG1 |
| Immunogen |
Purified bovine kidney calbindin-D-28K |
| Localization |
Cytoplasm, Cell Membrane |
Calbindin
|
Diagnostic Biosystems |
CB-955 |
1 ml |
Concentrate |
CE/IVD |
MOB554 |
-
|
| Host |
Mouse |
| Clone |
CB-955 |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Citrate, Enzyme |
| Positive control |
Kidney |
| Dilution |
1:150 - 1:300 |
| Isotype |
Mouse IgG1 |
| Immunogen |
Purified bovine kidney calbindin-D-28K |
| Localization |
Cytoplasm, Cell Membrane |
Calbindin
|
Diagnostic Biosystems |
CB-955 |
0.1 ml |
Concentrate |
CE/IVD |
MOB554-01 |
-
|
| Host |
Mouse |
| Clone |
CB-955 |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Citrate, Enzyme |
| Positive control |
Kidney |
| Dilution |
1:150 - 1:300 |
| Isotype |
Mouse IgG1 |
| Immunogen |
Purified bovine kidney calbindin-D-28K |
| Localization |
Cytoplasm, Cell Membrane |
Calbindin
|
Diagnostic Biosystems |
CB-955 |
0.5 ml |
Concentrate |
CE/IVD |
MOB554-05 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Citrate |
| Positive control |
Thyroid, Medullary Carcinoma |
| Dilution |
1:300 |
| Isotype |
Rabbit IgG |
| Immunogen |
Synthetic human calcitonin 1-32 amino acid peptide. |
| Localization |
Cytoplasm |
Calcitonin
|
Zytomed Systems GmbH |
polyclonal |
1 ml |
Concentrate |
RUO |
503-1154 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Ready-to-use |
| Method |
F, P |
| Positive control |
Thyroid |
| Dilution |
- |
| Isotype |
Rabbit IgG |
| Localization |
Cytoplasm |
Calcitonin
|
Diagnostic Biosystems |
polyclonal |
6 ml |
Ready-to-use |
CE/IVD |
PDR024 |
-
|
| Host |
Rabbit |
| Clone |
SP17 |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Citrate |
| Positive control |
Medullary thyroid carcinoma |
| Dilution |
1:100 |
| Isotype |
Rabbit IgG |
| Immunogen |
Synthetic peptide of 32 amino acid residues corresponding to human Calcitonin |
| Localization |
Cytoplasm |
Calcitonin
|
Zytomed Systems GmbH |
SP17 |
1 ml |
Concentrate |
RUO |
RBK038 |
-
|
| Host |
Rabbit |
| Clone |
SP17 |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Citrate |
| Positive control |
Medullary thyroid carcinoma |
| Dilution |
1:100 |
| Isotype |
Rabbit IgG |
| Immunogen |
Synthetic peptide of 32 amino acid residues corresponding to human Calcitonin |
| Localization |
Cytoplasm |
Calcitonin
|
Zytomed Systems GmbH |
SP17 |
0.5 ml |
Concentrate |
RUO |
RBK038-05 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Concentrate |
| Method |
F, P |
| Positive control |
Thyroid |
| Dilution |
1:50 - 1:100 |
| Isotype |
Rabbit IgG |
| Localization |
Cytoplasm |
Calcitonin
|
Diagnostic Biosystems |
polyclonal |
1 ml |
Concentrate |
CE/IVD |
RP050 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Concentrate |
| Method |
F, P |
| Positive control |
Thyroid |
| Dilution |
1:50 - 1:100 |
| Isotype |
Rabbit IgG |
| Localization |
Cytoplasm |
Calcitonin
|
Diagnostic Biosystems |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
RP050-01 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Concentrate |
| Method |
F, P |
| Positive control |
Thyroid |
| Dilution |
1:50 - 1:100 |
| Isotype |
Rabbit IgG |
| Localization |
Cytoplasm |
Calcitonin
|
Diagnostic Biosystems |
polyclonal |
0.5 ml |
Concentrate |
CE/IVD |
RP050-05 |
-
|
| Host |
Mouse |
| Clone |
ZM301 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Thyroid or medullary carcinoma |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG2b /κ |
| Immunogen |
Recombinant fragment of human Calcitonin protein (around aa 3-116) |
| Localization |
Cytoplasm |
Calcitonin
|
Zeta Corporation |
ZM301 |
1 ml |
Concentrate |
CE/IVD |
Z2731ML |
-
|
| Host |
Mouse |
| Clone |
ZM301 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Thyroid or medullary carcinoma |
| Dilution |
- |
| Isotype |
IgG2b /κ |
| Immunogen |
Recombinant fragment of human Calcitonin protein (around aa 3-116) |
| Localization |
Cytoplasm |
Calcitonin
|
Zeta Corporation |
ZM301 |
7 ml |
Concentrate |
CE/IVD |
Z2731MP |
-
|
| Host |
Mouse |
| Clone |
ZM301 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Thyroid or medullary carcinoma |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG2b /κ |
| Immunogen |
Recombinant fragment of human Calcitonin protein (around aa 3-116) |
| Localization |
Cytoplasm |
Calcitonin
|
Zeta Corporation |
ZM301 |
0.5 ml |
Concentrate |
CE/IVD |
Z2731MS |
-
|
| Host |
Mouse |
| Clone |
ZM301 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Thyroid or medullary carcinoma |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG2b /κ |
| Immunogen |
Recombinant fragment of human Calcitonin protein (around aa 3-116) |
| Localization |
Cytoplasm |
Calcitonin
|
Zeta Corporation |
ZM301 |
0.1 ml |
Concentrate |
CE/IVD |
Z2731MT |
-
|
| Host |
Goat |
| Clone |
polyclonal |
| Format |
Purified |
| Method |
IF, P, EL |
| Dilution |
1:200 - 1:1600 (P) |
| Isotype |
Goat IgG |
| Immunogen |
Synthetic rat Tyr-CGRP (23-37) conjugated to gamma globulin |
Calcitonin Gene-Related Peptide (CGRP)
|
Zytomed Systems GmbH |
polyclonal |
100 µl |
Purified |
RUO |
603-0030 |
-
|
| Host |
Mouse |
| Clone |
hHCD |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
EDTA |
| Positive control |
Endometrial cancer |
| Dilution |
1:50 - 1:100 |
| Isotype |
IgG1 kappa |
| Localization |
Cytoplasm |
Caldesmon
|
Diagnostic Biosystems |
hHCD |
1 ml |
Concentrate |
CE/IVD |
MOB556 |
-
|
| Host |
Mouse |
| Clone |
hHCD |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
EDTA |
| Positive control |
Endometrial cancer |
| Dilution |
1:50 - 1:100 |
| Isotype |
IgG1 kappa |
| Localization |
Cytoplasm |
Caldesmon
|
Diagnostic Biosystems |
hHCD |
0.1 ml |
Concentrate |
CE/IVD |
MOB556-01 |
-
|
| Host |
Mouse |
| Clone |
hHCD |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
EDTA |
| Positive control |
Endometrial cancer |
| Dilution |
1:50 - 1:100 |
| Isotype |
IgG1 kappa |
| Localization |
Cytoplasm |
Caldesmon
|
Diagnostic Biosystems |
hHCD |
0.5 ml |
Concentrate |
CE/IVD |
MOB556-05 |
-
|
| Host |
Mouse |
| Clone |
hHCD |
| Format |
Ready-to-use |
| Method |
P |
| Pretreatment |
EDTA |
| Positive control |
Endometrial cancer |
| Dilution |
- |
| Isotype |
IgG1 kappa |
| Localization |
Cytoplasm |
Caldesmon
|
Diagnostic Biosystems |
hHCD |
6 ml |
Ready-to-use |
CE/IVD |
PDM223 |
-
|
| Host |
Mouse |
| Clone |
hHCD |
| Format |
Ready-to-use |
| Method |
P |
| Pretreatment |
EDTA |
| Positive control |
Endometrial cancer |
| Dilution |
- |
| Isotype |
IgG1 kappa |
| Localization |
Cytoplasm |
Caldesmon
|
Diagnostic Biosystems |
hHCD |
25 ml |
Ready-to-use |
CE/IVD |
PDM223-25 |
-
|
| Host |
Mouse |
| Clone |
ZM79 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Uterus, colon carcinoma. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant full-length human CALD1 protein |
| Localization |
Cytoplasm |
Caldesmon
|
Zeta Corporation |
ZM79 |
1.0 ml |
Concentrate |
CE/IVD |
Z2389ML |
-
|
| Host |
Mouse |
| Clone |
ZM79 |
| Format |
Ready-to-use |
| Reactivity |
- |
| Method |
P |
| Positive control |
Uterus, colon carcinoma. |
| Dilution |
- |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant full-length human CALD1 protein |
| Localization |
Cytoplasm |
Caldesmon
|
Zeta Corporation |
ZM79 |
7 ml |
Ready-to-use |
CE/IVD |
Z2389MP |
-
|
| Host |
Mouse |
| Clone |
ZM79 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Uterus, colon carcinoma. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant full-length human CALD1 protein |
| Localization |
Cytoplasm |
Caldesmon
|
Zeta Corporation |
ZM79 |
0.5 ml |
Concentrate |
CE/IVD |
Z2389MS |
-
|
| Host |
Mouse |
| Clone |
ZM79 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Uterus, colon carcinoma. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant full-length human CALD1 protein |
| Localization |
Cytoplasm |
Caldesmon
|
Zeta Corporation |
ZM79 |
0.1 ml |
Concentrate |
CE/IVD |
Z2389MT |
-
|
| Host |
Rabbit |
| Clone |
SP81 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Breast carcinoma |
| Dilution |
1:100 |
| Isotype |
Rabbit IgG |
| Immunogen |
A synthetic peptide derived from internal region of human calpain protein |
| Localization |
Cytoplasm |
Calpain
|
Zytomed Systems GmbH |
SP81 |
1 ml |
Concentrate |
RUO |
503-3814 |
-
|
| Host |
Mouse |
| Clone |
CALP |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Trypsin |
| Positive control |
Breast Carcinoma |
| Dilution |
1:50 - 1:100 |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm |
Calponin
|
Diagnostic Biosystems |
CALP |
1 ml |
Concentrate |
CE/IVD |
MOB345 |
-
|
| Host |
Mouse |
| Clone |
CALP |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Trypsin |
| Positive control |
Breast Carcinoma |
| Dilution |
1:50 - 1:100 |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm |
Calponin
|
Diagnostic Biosystems |
CALP |
0.1 ml |
Concentrate |
CE/IVD |
MOB345-01 |
-
|
| Host |
Mouse |
| Clone |
CALP |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Trypsin |
| Positive control |
Breast Carcinoma |
| Dilution |
1:50 - 1:100 |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm |
Calponin
|
Diagnostic Biosystems |
CALP |
0.5 ml |
Concentrate |
CE/IVD |
MOB345-05 |
-
|
| Host |
Mouse |
| Clone |
CALP |
| Format |
Ready-to-use |
| Method |
F, P |
| Pretreatment |
Trypsin |
| Positive control |
Breast Carcinoma |
| Dilution |
- |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm |
Calponin
|
Diagnostic Biosystems |
CALP |
6 ml |
Ready-to-use |
CE/IVD |
PDM219 |
-
|
| Host |
Mouse |
| Clone |
CALP |
| Format |
Ready-to-use |
| Method |
F, P |
| Pretreatment |
Trypsin |
| Positive control |
Breast Carcinoma |
| Dilution |
- |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm |
Calponin
|
Diagnostic Biosystems |
CALP |
25 ml |
Ready-to-use |
CE/IVD |
PDM219-25 |
-
|
| Host |
Mouse |
| Clone |
ZM21 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Normal breast tissue. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human CNN1 protein |
| Localization |
Cytoplasm |
Calponin-1
|
Zeta Corporation |
ZM21 |
1.0 ml |
Concentrate |
CE/IVD |
Z2341ML |
-
|
| Host |
Mouse |
| Clone |
ZM21 |
| Format |
Ready-to-use |
| Reactivity |
- |
| Method |
P |
| Positive control |
Normal breast tissue. |
| Dilution |
- |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human CNN1 protein |
| Localization |
Cytoplasm |
Calponin-1
|
Zeta Corporation |
ZM21 |
7 ml |
Ready-to-use |
CE/IVD |
Z2341MP |
-
|
| Host |
Mouse |
| Clone |
ZM21 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Normal breast tissue. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human CNN1 protein |
| Localization |
Cytoplasm |
Calponin-1
|
Zeta Corporation |
ZM21 |
0.5 ml |
Concentrate |
CE/IVD |
Z2341MS |
-
|
| Host |
Mouse |
| Clone |
ZM21 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Normal breast tissue. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human CNN1 protein |
| Localization |
Cytoplasm |
Calponin-1
|
Zeta Corporation |
ZM21 |
0.1 ml |
Concentrate |
CE/IVD |
Z2341MT |
-
|
| Host |
Rabbit |
| Clone |
ZR297 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Normal breast tissue |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG |
| Immunogen |
Recombinant human full-length CNN1 protein |
| Localization |
Cytoplasm |
Calponin-1
|
Zeta Corporation |
ZR297 |
1 ml |
Concentrate |
CE/IVD |
Z2612RL |
-
|
| Host |
Rabbit |
| Clone |
ZR297 |
| Format |
Ready-to-use |
| Reactivity |
- |
| Method |
P |
| Positive control |
Normal breast tissue |
| Dilution |
- |
| Isotype |
IgG |
| Immunogen |
Recombinant human full-length CNN1 protein |
| Localization |
Cytoplasm |
Calponin-1
|
Zeta Corporation |
ZR297 |
7 ml |
Ready-to-use |
CE/IVD |
Z2612RP |
-
|
| Host |
Rabbit |
| Clone |
ZR297 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Normal breast tissue |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG |
| Immunogen |
Recombinant human full-length CNN1 protein |
| Localization |
Cytoplasm |
Calponin-1
|
Zeta Corporation |
ZR297 |
0.5 ml |
Concentrate |
CE/IVD |
Z2612RS |
-
|
| Host |
Rabbit |
| Clone |
ZR297 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Normal breast tissue |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG |
| Immunogen |
Recombinant human full-length CNN1 protein |
| Localization |
Cytoplasm |
Calponin-1
|
Zeta Corporation |
ZR297 |
0.1 ml |
Concentrate |
CE/IVD |
Z2612RT |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM85 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Mesothelioma |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human Calretinin (Calbindin 2) protein fragment (around aa23-242) |
| Localization |
Cytoplasm and Nucleus |
Calretinin
|
Zeta Corporation |
ZM85 |
1 ml |
Concentrate |
CE/IVD |
Z2392ML |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM85 |
| Format |
Ready-to-use |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Mesothelioma |
| Dilution |
- |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human Calretinin (Calbindin 2) protein fragment (around aa23-242) |
| Localization |
Cytoplasm and Nucleus |
Calretinin
|
Zeta Corporation |
ZM85 |
7 ml |
Ready-to-use |
CE/IVD |
Z2392MP |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM85 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Mesothelioma |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human Calretinin (Calbindin 2) protein fragment (around aa23-242) |
| Localization |
Cytoplasm and Nucleus |
Calretinin
|
Zeta Corporation |
ZM85 |
0.5 ml |
Concentrate |
CE/IVD |
Z2392MS |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM85 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Mesothelioma |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human Calretinin (Calbindin 2) protein fragment (around aa23-242) |
| Localization |
Cytoplasm and Nucleus |
Calretinin
|
Zeta Corporation |
ZM85 |
0.1 ml |
Concentrate |
CE/IVD |
Z2392MT |
-
|
| Host |
Mouse |
| Clone |
231/439 |
| Format |
Purified |
| Method |
EL |
| Isotype |
Mouse IgG |
| Immunogen |
Native Candida albicans |
Candida albicans
|
Zytomed Systems GmbH |
231/439 |
200 µg |
Purified |
RUO |
603-0059 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Purified |
| Method |
F, EL, IF |
| Isotype |
Rabbit IgG |
Candida albicans
|
Zytomed Systems GmbH |
polyclonal |
1 ml |
Purified |
RUO |
603-0061 |
-
|
| Host |
Rabbit |
| Clone |
polyclonal |
| Format |
Biotin |
| Method |
F, IF, EL, WB |
| Isotype |
Rabbit IgG |
| Immunogen |
Native Candida albicans |
Candida albicans (Type A) - Biotin
|
Zytomed Systems GmbH |
polyclonal |
1 ml |
Biotin |
RUO |
603-0063 |
-
|
| Host |
Mouse |
| Clone |
CPVI-2AI |
| Format |
Purified |
| Method |
EL, P |
| Isotype |
Mouse IgG2a |
Canine/Feline Parvovirus (CPV)
|
Zytomed Systems GmbH |
CPVI-2AI |
250 µg |
Purified |
RUO |
603-0071 |
-
|